Clinical Trials Logo

Azithromycin Adverse Reaction clinical trials

View clinical trials related to Azithromycin Adverse Reaction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04699097 Completed - Covid19 Clinical Trials

The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children

Start date: July 1, 2020
Phase:
Study type: Observational

Azithromycin (AZ) is used in the pediatric group in COVID-19 diseas. It has been reported to cause prolongation in the QT interval in adult age group. The aim of this study is to evaluate the effect of AZ on ventricular repolarization in COVID-19 positive pediatric patients. METHOD The study was conducted prospectively in July-August 2020. COVID-19 pediatric patients who received AZ treatment were included in the study. ECG was obtained before treatment and on the 1st, 3rd and 5th days after the treatment. Measurements were made with Image J program®. QTmax, QTmin, Tp-emax, Tp-emin intervals were measured. QTcmax, QTcmin, Tp-ecmax, Tp-ecmin, QTcd, Tp-ecd, and QTc / Tp-ec ratios were calculated with Bazett formula.